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Andrea Prodosmo1, Amelia Buffone4, Manlio Mattioni1, Agnese Barnabei3, Agnese Persichetti3,4, Aurora De Leo3,
Marialuisa Appetecchia3, Arianna Nicolussi11, Anna Coppa11, Salvatore Sciacchitano5, Carolina Giordano6,
Paola Pinnarò6, Giuseppe Sanguineti6, Lidia Strigari7, Gabriele Alessandrini8, Francesco Facciolo8,
Maurizio Cosimelli9, Gian Luca Grazi9, Giacomo Corrado10, Enrico Vizza10, Giuseppe Giannini2,4* and Silvia Soddu1*Erratum
In original publication of this article [1], the data for
“Pat#7” in Additional file 1 was listed as “c.4436+24G>A”
in the “Nucleotide change” column. Instead, the number
should have been c.4436+24A>G.Additional file
Additional file 1: Characteristics of ATM variants. (DOCX 16 kb)
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